Oppenheimer & CO Inc A Tyr Pharma Inc Transaction History

Oppenheimer & CO Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.23 - $5.39 $59,247 - $98,868	-18,343 Closed	0 $0
Q2 2020 Aug 11, 2020	SELL	$2.55 - $4.58 $1,524 - $2,738	-598 Reduced 3.16%	18,343 $81,000
Q1 2020 May 08, 2020	BUY	$2.17 - $7.06 $41,101 - $133,723	18,941 New	18,941 $53,000

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Oppenheimer & CO Inc with notifications on news.